Clarification of the behavioral functions of peripheral and central cholecystokinin: two separate peptide pools.

No abstract is available for this paper.

• Publication year

  1985

• Venue

  Peptides

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/0196-9781(85)90145-7PMID 3001671
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Antagonists of central and peripheral behavioral actions of cholecystokinin octapeptide.

  1986cited by this paper
• Antagonism of Cholecystokinin by Naloxone and Proglumide in Mice

  1985cited by this paper
• Behavioral evidence for cholecystokinin modulation of dopamine in the mesolimbic pathway.

  1985cited by this paper
• Psychopharmacological Profile of Cholecystokinin Using the Self‐Stimulation and the Drug Discrimination Paradigms a

  1985cited by this paper
• Cholecystokinin Potentiation of Dopamine‐mediated Behaviors in the Nucleus Accumbens

  1985cited by this paper
• Cholecystokinin potentiates dopamine-mediated behaviors: evidence for modulation specific to a site of coexistence

  1985cited by this paper
• Topographical analysis of nucleus accumbens sites at which cholecystokinin potentiates dopamine-induced hyperlocomotion in the rat.

  1985cited by this paper
• Behavioral evidence for cholecystokinin modulation of dopamine in the mesolimbic pathway.

  1985cited by this paper
• Neurochemical investigation of the afferent pathway from the vagus nerve to the nucleus tractus solitarius in mediating the "satiety syndrome" induced by systemic cholecystokinin.

  1985cited by this paper
• Increased Food Intake in the Rat Caused by Proglumide, the Cholecystokinin Antagonist An Effect Abolished by Vagotomy

  1985cited by this paper
• The Effects of Cholecystokinin‐like Peptides in Schizophrenics and Normal Human Subjects

  1985cited by this paper
• Tracing the Sensory Pathway from the Gut to Brain Regions Mediating the Actions of Cholecystokinin on Feeding and Exploration

  1985cited by this paper
• Central versus Peripheral Cholecystokinin Octapeptide on Self‐Stimulation and Locomotor Activity in the Rat

  1985cited by this paper
• The Effects of Cholecystokinin Octapeptide and Proglumide on Electrically Elicited Eating

  1985cited by this paper
• Paraventricular nucleus lesions abolish the inhibition of feeding induced by systemic cholecystokinin.

  1985cited by this paper
• Cholecystokinin-induced suppression of feeding: an evaluation of the generality of gustatory-cholecystokinin interactions.

  1984cited by this paper
• Bilateral midbrain transections block the behavioral effects of cholecystokinin on feeding and exploration in rats.

  1984cited by this paper
• Morphine analgesia potentiated but tolerance not affected by active immunization against cholecystokinin.

  1984cited by this paper
• Area postrema: site where cholecystokinin acts to decrease food intake.

  1984cited by this paper
• The cholecystokinin analogue, caerulein, does not modulate dopamine release or dopamine-induced locomotor activity in the nucleus accumbens of rat.

  1984cited by this paper
• Cholecystokinin-octapeptide produces inhibition of lordosis in the female rat.

  1984cited by this paper
• Different effects of cholecystokinin and satiety on lateral hypothalamic self-stimulation.

  1984cited by this paper
• Potentiation of opiate analgesia and apparent reversal of morphine tolerance by proglumide.

  1984cited by this paper
• Analysis of the behavioral activity of C- and N-terminal fragments of cholecystokinin octapeptide.

  1984cited by this paper
• Cholecystokinin tetrapeptide, proglumide and open-field behavior in rats.

  1984cited by this paper
• Behavioral and neurophysiological evidence for a facilatory interaction between co-existing transmitters: cholecystokinin and dopamine.

  1984cited by this paper
• Effects of systemically administered cholecystokinin-octapeptide on local cerebral metabolism.

  1984cited by this paper
• No evidence of antipsychotic effect of caerulein in schizophrenic patients free of neuroleptics: a double-blind cross-over study.

  1984cited by this paper
• Abolition of the behavioral effects of cholecystokinin following bilateral radiofrequency lesions of the parvocellular subdivision of the nucleus tractus solitarius.

  1984cited by this paper
• Cholecystokinin accelerates the rate of habituation to a novel environment.

  1984cited by this paper
• Suppression of feeding by cholecystokinin but not bombesin is attenuated in dorsomedial hypothalamic nuclei lesioned rats.

  1984cited by this paper
• Interactions of cholecystokinin octapeptide and dopamine on nucleus accumbens neurons.

  1984cited by this paper
• CHOLECYSTOKININ: POTENTIAL PEPTIDERGIC ANTIPSYCHOTIC

  1984cited by this paper
• Microinjections of nanogram amounts of sulfated cholecystokinin octapeptide into the rat nucleus accumbens attenuates brain stimulation reward.

  1984cited by this paper
• Further analysis of the effects of cholecystokinin octapeptides on avoidance behaviour in rats.

  1984cited by this paper
• Nucleus tractus solitarius lesions block the behavioral actions of cholecystokinin.

  1983cited by this paper
• Continuous infusion of cholecystokinin and meal pattern in the rat.

  1983cited by this paper
• Divergent effects of cholecystokinin, bombesin, and lithium on rat exploratory behaviors.

  1983cited by this paper
• Feeding behavior response of Zucker rats to proglumide, a CCK receptor antagonist.

  1983cited by this paper
• CCK-8 modulation of mesolimbic dopamine: antagonism of amphetamine-stimulated behaviors.

  1983cited by this paper
• Evidence for the neuropeptide cholecystokinin as an antagonist of opiate analgesia.

  1983cited by this paper
• Feeding and drinking responses in the golden hamster following treatment with cholecystokinin and angiotensin II.

  1983cited by this paper
• In rats, the behavioral profile of CCK-8 related peptides resembles that of antipsychotic agents.

  1983cited by this paper
• The sites of action of cholecystokinin in decreasing meal size in pigs.

  1983cited by this paper
• Rapid development of tolerance to the behavioural actions of cholecystokinin

  1983cited by this paper
• The effects of proglumide on cholecystokinin-, bombesin-, and glucagon-induced satiety in the rat.

  1983cited by this paper
• Cholecystokinin produces conditioned place-aversions, not place-preferences, in food-deprived rats: evidence against involvement in satiety.

  1983cited by this paper
• Minimized tolerance to the suppressive effects of CCK8 on operant responding.

  1983cited by this paper
• Influence of cholecystokinin on central monoaminergic pathways.

  1983cited by this paper
• Effect of cholecystokinin on thyrotropin releasing hormone (TRH)-induced serotonin potentiation in rats.

  1982cited by this paper
• Analgesic effect of intrathecal morphine demonstrated in ascending nociceptive activity in the rat spinal cord an in effectiveness of caerulein and cholecystokinin octapeptide.

  1982cited by this paper
• Ceruletide increases threshold and tolerance to experimentally induced pain in healthy man.

  1982cited by this paper
• Cholecystokinin suppresses food intake by inhibiting gastric emptying.

  1982cited by this paper
• Electroencephalographic analysis of the sleep-inducing actions of cholecystokinin.

  1982cited by this paper
• The C-terminal tetrapeptide of cholecystokinin decreases hunger in rats

  1982cited by this paper
• The role of central and peripheral cholecystokinin in mediating appetitive behaviors.

  1982cited by this paper
• Caerulfin and cholecystokinin octapeptide (CCK-8): Sedative and anticonvulsive effects in mice unaffected by the benzodiazepine antagonist Ro 15-1788

  1982cited by this paper
• Cholecystokinin octapeptide decreases intake of solid food in man.

  1982cited by this paper
• The central distribution of the cervical vagus nerve and gastric afferent and efferent projections in the rat.

  1982cited by this paper
• Central regulation of intestinal motility by somatostatin and cholecystokinin octapeptide.

  1982cited by this paper
• Respiratory and cardiovascular effects of intraventricular cholecystokinin.

  1982cited by this paper
• The effect of vagotomy on the satiety effects of neuropeptides and naloxone.

  1982cited by this paper
• Cholecystokinin-octapeptide effects on eating elicited by "external" versus "internal" cues in rats.

  1982cited by this paper
• Vagal mediation of the cholecystokinin satiety effect in rats.

  1982cited by this paper
• Effect of cholecystokinin octapeptide and vasoactive intestinal polypeptide on adrenocortical secretion in the rat.

  1982cited by this paper
• Eating, drinking and temperature responses to intracerebroventricular cholecystokinin in the chick.

  1982cited by this paper
• Rapid appearance of intraventricularly administered neuropeptides in the peripheral circulation.

  1982cited by this paper
• Cholecystokinin appears to have antipsychotic properties

  1982cited by this paper
• Antipsychotic Effects of Ceruletide (Caerulein) on Chronic Schizophrenia

  1982cited by this paper
• Antipsychotic effects of ceruletide (caerulein) on chronic schizophrenia.

  1982cited by this paper
• Vagotomy abolishes the inhibitory effects of cholecystokinin on rat exploratory behaviors

  1981cited by this paper
• Abdominal vagotomy blocks the satiety effect of cholecystokinin in the rat.

  1981cited by this paper
• Intraventricular cholecystokinin-octapeptide produces hypothermia in rats.

  1981cited by this paper
• Cholecystokinin satiety and orosensory feedback.

  1981cited by this paper
• Peptide-monoamine coexistence: studies of the actions of cholecystokinin-like peptide on the electrical activity of midbrain dopamine neurons.

  1981cited by this paper
• Brain-gut peptides and the control of food intake.

  1981cited by this paper
• Cholecystokinin reduces exploratory behavior in mice.

  1981cited by this paper
• Peripheral and intrahypothalamic cholecystokinin act on the noradrenergic "feeding circuit" in the rat's diencephalon.

  1981cited by this paper
• Neuropeptide modulation of social and exploratory behaviors in laboratory rodents.

  1981cited by this paper
• Effect of cholecystokinin octapeptide on body temperature in the rat.

  1981cited by this paper
• Effects of cholecystokinin octapeptide on striatal dopamine metabolism and on apomorphine-induced stereotyped cage-climbing in mice.

  1981cited by this paper
• Operant feeding and drinking in pigs following intracerebroventricular injection of synthetic cholecystokinin octapeptide.

  1981cited by this paper
• Cholecystokinin antibody injected in cerebral ventricles stimulates feeding in sheep.

  1981cited by this paper
• C-terminal octapeptide of cholecystokinin decreases food intake in man.

  1981cited by this paper
• Degradation of cholecystokinin-like peptides by a crude rat brain synaptosomal fraction: a study by high pressure liquid chromatography.

  1981cited by this paper
• Antinociceptive effect of centrally administered caerulein and cholecystokinin octapeptide (CCK-8)☆

  1981cited by this paper
• A subpopulation of mesencephalic dopamine neurons projecting to limbic areas contains a cholecystokinin-like peptide: evidence from immunohistochemistry combined with retrograde tracing.

  1980cited by this paper
• Entry of opioid peptides into the central nervous system.

  1980cited by this paper
• The feeding response of obese mice (genotype, ob ob) and their wild-type littermates to cholecystokinin (pancreozymin).

  1980cited by this paper
• Analgesia and ptosis caused by caerulein and cholecystokinin octapeptide (CCK-8).

  1980cited by this paper
• Effects of cholecystokinin-like peptides on rearing activity and hexobarbital-induced sleep.

  1980cited by this paper
• Evidence for coexistence of dopamine and CCK in meso-limbic neurones

  1980cited by this paper
• Anticonvulsant effects of careulein and cholecystokinin octapeptide, compared with those of diazepam.

  1980cited by this paper
• An autoradiographic examination of the central distribution of the trigeminal, facial, glossopharyngeal, and vagal nerves in the monkey

  1979cited by this paper
• Cholecystokinin suppresses sham feeding in the rhesus monkey.

  1979cited by this paper
• Cholecystokinin decreases appetite and activation evoked by stimuli arising from the preparation of a meal in man.

  1979cited by this paper
• CNS effects of peripherally administered brain peptides.

  1979cited by this paper
• Age-dependent inhibition of suckling by cholecystokinin.

  1979cited by this paper
• Gastrin in human cerebrospinal fluid: lack of correlation with serum concentrations.

  1979cited by this paper
• Cholecystokinin octapeptide: continuous picomole injections into the cerebral ventricles of sheep suppress feeding.

  1979cited by this paper

• Cholecystokinin (CCK)‐expressing neurons in the suprachiasmatic nucleus: innervation, light responsiveness and entrainment in CCK‐deficient mice

  2010cites this paper
• METABOLIC SIGNALS IN SLEEP REGULATION: THE ROLE OF CHOLECYSTOKININ

  2010cites this paper
• METABOLIC SIGNALS IN SLEEP REGULATION : THE ROLE OF CHOLECYSTOKININ

  2010cites this paper
• Structure-activity relationships of CCK26-33-related analogues modified in position 33

  2009cites this paper
• Synthesis of cyclic analogues of cholecystokinin highly selective for central receptors.

  2009cites this paper
• Actions of appetite regulating peptides on supraoptic nucleus (SON) oxytocin neurones

  2009cites this paper
• Characterization of the feeding inhibition and neural activation produced by dorsomedial hypothalamic cholecystokinin administration.

  2008cites this paper
• Ceruletide, an analog of cholecystokinin octapeptide: New perspectives on its efficacy

  2006cites this paper
• Cholecystokinin And Satiety

  2006cites this paper
• Hyperphagia and obesity in OLETF rats lacking CCK-1 receptors

  2006cites this paper
• Differential roles for cholecystokinin a receptors in energy balance in rats and mice.

  2004cites this paper
• Central d-Ala2-Met5-enkephalinamide μ/δ-opioid receptor activation reverses the anxiogenic-like properties of cholecystokinin on locomotor and rearing activity in CD-1 mice

  2003cites this paper
• Central D-Ala2-Met5-enkephalinamide mu/delta-opioid receptor activation reverses the anxiogenic-like properties of cholecystokinin on locomotor and rearing activity in CD-1 mice.

  2003cites this paper
• Differential startle reactivity following central CCK-8S and systemic Boc CCK-4 administration in mice: antecedent stressor history and testing condition.

  2003cites this paper
• Central Cholecystokinin‐Octapeptide Accelerates the Activity of the Hypothalamic Gonadotropin‐Releasing Hormone Pulse Generator in Goats

  2003cites this paper
• Actions of CCK in the controls of food intake and body weight: lessons from the CCK-A receptor deficient OLETF rat.

  2002cites this paper
• Food for thought: a critique on the hypothesis that endogenous cholecystokinin acts as a physiological satiety factor

  1998cites this paper
• Cholecystokinin receptors do not mediate the behavioral effects of lipopolysaccharide in mice.

  1997cites this paper
• Optimization of 3-(1H-indazol-3-ylmethyl)-1,5-benzodiazepines as potent, orally active CCK-A agonists.

  1997cites this paper
• 3-[2-(N-phenylacetamide)]-1,5-benzodiazepines: orally active, binding selective CCK-A agonists.

  1996cites this paper
• Intracerebroventricular injection of CCK reduces operant sugar intake in pigs.

  1996cites this paper
• 3-(1H-indazol-3-ylmethyl)-1,5-benzodiazepines: CCK-A agonists that demonstrate oral activity as satiety agents.

  1996cites this paper
• Inhibitory effects of cholecystokinin on rat's geniculate activity can be blocked by GABA-antagonists.

  1995cites this paper
• Neurobiology of cholecystokinin.

  1994cites this paper
• Oxytocin neurone adaptations to opioids

  1994cites this paper
• Effect of a novel CCKA receptor antagonist (2-NAP) on the reduction in food intake produced by CCK in pigs.

  1994cites this paper
• Role of endogenous corticotropin-releasing factor in mediation of neuroendocrine and behavioral responses to cholecystokinin octapeptide sulfate ester in rats.

  1993cites this paper
• Cholecystokinin antagonists--a toxicologic perspective.

  1992cites this paper
• Cholecystokinin antagonists--a toxicologic perspective.

  1992cites this paper
• Depolarizing action of cholecystokinin on rat supraoptic neurones in vitro.

  1992cites this paper
• Centrally administered cholecystokinin suppresses feeding through a peripheral-type receptor mechanism.

  1991cites this paper
• Acute reduction and long-term improvement of chorea with ceruletide (cholecystokinin analogue).

  1990cites this paper
• IVT CCK-8 is more effective than IV CCK-8 at decreasing meal size in the baboon.

  1989cites this paper
• Synthesis and binding affinities of cyclic and related linear analogues of CCK8 selective for central receptors.

  1989cites this paper
• Cholecystokinin concentration in specific brain areas of rats fed during the light or dark phase of the circadian cycle.

  1989cites this paper
• Cyclic cholecystokinin analogues with high selectivity for central receptors.

  1988cites this paper
• Central Actions of Peripherally Administered Gut Peptides, with Particular Reference to Cholecystokinin

  1988cites this paper
• Interaction of Memantine with Cholecystokinin Receptors in Mouse Brain

  1988cites this paper
• The G.L. Brown lecture. Regulatory peptides and the neuroendocrinology of gut-brain relations.

  1988cites this paper
• Effects of nocturnal intraperitoneal administration of cholecystokinin in rats: simultaneous increase in sleep, increase in EEG slow-wave activity, reduction of motor activity, suppression of eating, and decrease in brain temperature.

  1988cites this paper
• Opposite actions of CCK-8 on amphetamine-induced hyperlocomotion and stereotypy following intracerebroventricular and intra-accumbens injections in rats.

  1988cites this paper
• Chapter 6 Neuropeptides and Their Processing: Targets for Drug Design

  1987cites this paper
• Potency of CR 1409, a new proglumide analog, on cholecystokinin-mediated behaviors and receptor binding.

  1987cites this paper
• Central nervous system effects of peptides, 1980-1985: a cross-listing of peptides and their central actions from the first six years of the journal Peptides.

  1986cites this paper
• Antinociceptive profile of sulfated CCK-8. Comparison with CCK-4, unsulfated CCK-8 and other neuropeptides.

  1986cites this paper